Clinical trial

Dose Finding Study of Il-2 at Ultra-low Dose in Children With Recently Diagnosed Type 1 Diabetes

NCT01862120

Study summary

ClinicalTrials.gov

Dose Finding Study of Il-2 at Ultra-low Dose in Children With Recently Diagnosed Type 1 Diabetes

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Dose D1 of interleukin-2 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention placebo Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Dose D2 of Interleukin-2 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Dose D3 of interleukin-2 Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-06-27

PhasePHASE2

Conditions

Type 1 Diabetesverified · MONDO: type 1 diabetes mellitus

Interventions

Dose D1 of interleukin-2DRUG

placeboDRUG

Dose D2 of Interleukin-2DRUG

Dose D3 of interleukin-2DRUG

Sponsors & collaborators

Assistance Publique - Hôpitaux de Parislead sponsor

Mapped research locations

ParisFrance4 NîmesFrance1 Le Kremlin-BicêtreFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01862120 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.